EP2329821
Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.11.2006EP published:
22.8.2012EP application number:
10170798.2
EPO information:
European Patent Register
Max expiry date:
28.11.2026
Title:
Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema
Timeline
Today
29.11.2006EP application
22.8.2012EP Publication
Owner
Name:
GlaxoSmithKline LLCAddress:
One Franklin Plaza 200 North 16th Street, 19102, Philadelphia, PA, US
Inventor
Name:
Brigandi, Richard AnthonyAddress:
Collegeville, PA, US
Name:
Levick, MarkAddress:
Collegeville, PA, US
Name:
Miller, William HenryAddress:
Collegeville, PA, US
Priority
Number:
740478 PDate:
29.11.2005Country:
US
Classification
Categories:
A61K 31/506, A61P 27/02, A61K 31/55, A61K 31/7052, A61K 39/395